Phosphorylcholine Copolymers Reviewed From Synthesis to Drug Delivery

A newly published review in Discover Polymers brings together the synthesis methods, physicochemical characterization techniques, and biological activities of amphiphilic copolymers bearing pendant phosphorylcholine groups, a class of zwitterionic materials designed to mimic the outer surface of cell membranes. The review, authored by Manas Barai and published on 12 October 2026 as an open-access article, focuses on copolymers built from 2-(methacryloyloxy)ethyl phosphorylcholine, abbreviated MPC, combined with hydrophobic methacrylate partners such as n-butyl methacrylate (BMA) and n-dodecyl methacrylate (DMA). Because the phosphorylcholine head group reproduces the charge-neutral, strongly hydrated architecture found in natural phospholipids, these polymers resist nonspecific protein adsorption and show low toxicity, properties that underpin their appeal in drug delivery, biosensing, and implant coatings.

The review organizes the field around two architectural families. Block copolymers, denoted PMPCn-b-PBMAm and PMPCn-b-PDMAm, place a hydrophilic phosphorylcholine block beside a hydrophobic block whose length is defined by the degree of polymerization. Random copolymers, written P(MPC/BMAx) and P(MPC/DMAx), distribute the two monomer units along the same chain, with x representing the molar percentage of the hydrophobic component. Both families self-assemble in water into micelles, vesicles, and larger aggregates, in which hydrophobic segments cluster into an inner core while phosphorylcholine groups form a biocompatible outer shell. That core-shell geometry is what allows the materials to solubilize poorly water-soluble drugs such as paclitaxel inside the hydrophobic interior while presenting a protein-repelling surface to the bloodstream.

Synthesis of the reviewed systems relies chiefly on reversible addition-fragmentation chain transfer (RAFT) radical polymerization, though the review also surveys atom transfer radical polymerization (ATRP), nitroxide-mediated polymerization (NMP), and ring-opening metathesis-style approaches as alternative controlled radical routes. In the representative RAFT procedure, MPC homopolymer is prepared in water using 4,4-azobis(4-cyanopentanoic acid) as initiator and 4-cyanopentanoic acid dithiobenzoate as chain transfer agent at 70 degrees Celsius, followed by a week of dialysis and freeze-drying. The resulting PMPC then serves as a macro-chain-transfer agent for the second step: block copolymerization with BMA in ethanol at 70 degrees for 24 hours, or one-step random copolymerization with DMA in a tetrahydrofuran-ethanol mixture at 60 degrees for 16 hours. The random route is described as operationally simpler, while the block route offers better-defined architectures that the review links to stronger therapeutic performance.

Characterization of these assemblies draws on a broad analytical toolkit. Proton nuclear magnetic resonance spectroscopy reveals restricted molecular motion: in PMPCn-b-PBMAm, the n-butyl signals broaden because hydrophobic interactions immobilize the butyl side chains, and in P(MPC/DMAx) both the DMA methylene protons and the MPC pendant groups show restricted mobility as MPC units become trapped in hydrophobic microdomains. Fluorescence spectroscopy with pyrene, monitored through the ratio of the third to first vibronic emission peaks, tracks the polarity change around the probe and confirms hydrophobic association of the n-dodecyl groups; the aggregation number of P(MPC/DMAx) increases with rising DMA content. For the block copolymers, the probe N-phenyl-1-naphthylamine shifts its emission maximum as it penetrates the micellar core, allowing critical micelle concentration values to be determined.

Static and dynamic light scattering add structural and dimensional information. Static light scattering, analyzed through Zimm plots of P(MPC/DMAx) in 0.1 M sodium chloride, shows second virial coefficients that diminish as DMA content rises, consistent with the growing prevalence of n-dodecyl groups in the polymer segments. The data support a picture of interpolymer aggregates whose hydrophobic cores are coated with hydrophilic phosphorylcholine groups. Dynamic light scattering demonstrates that the hydrodynamic sizes of PMPCn-b-PBMAm micelles increase gradually with increasing PBMA block length. Electron microscopy complements these solution measurements: transmission electron microscopy of P(MPC/DMA19) shows particle sizes between roughly 56 and 100 nanometers, smaller than the 103 to 240 nanometer hydrodynamic diameters obtained by DLS, because TEM images dried, shrunken cores while DLS measures particles surrounded by hydration layers. PMPC56-b-PBMA80 micelles appear as regular spheres about 20 to 32 nanometers in diameter.

Surface behavior emerges as a key differentiator between the two architectures. Water contact angle measurements on coated substrates of polyethylene terephthalate, polycarbonate, polypropylene, acrylonitrile-butadiene-styrene, and stainless steel show that increasing polymer concentration drives the contact angle toward constant values of about 100 degrees for P(MPC/BMAx) and 110 degrees for P(MPC/DMAx), indicating complete surface coverage. Coating thicknesses range from 30 to 100 nanometers for P(MPC/DMAx), with 174 nanometers measured on ABS and 127 nanometers for P(MPC/BMAx) on polycarbonate. Notably, after a week of water immersion the P(MPC/DMAx) coating persists while the block copolymer PMPCn-b-PDMAm coating is stripped from the substrate, a contrast the review attributes to polymer reorganization in the random material versus removal of micellar block assemblies.

On the biological side, the review compiles evidence that these copolymers can act as nanocarriers for the anticancer drug paclitaxel. Solubility tests show that paclitaxel, which is poorly soluble in water and in PMPC solution, dissolves readily in P(MPC/BMAx) in a concentration-dependent manner: 2.0 milligrams of the drug dissolve completely in a 90 milligram-per-milliliter copolymer solution, and aggregates formed on cooling maintain the initial solubility for over a month. In cell studies with HeLa cells, P(MPC/DMAx) localized first to the plasma membrane after one hour of incubation, and cell viability assays recorded 15 percent and 9 percent cell death at 24 and 48 hours respectively, figures the review links to the cytotoxicity-reducing phosphorylcholine moiety. In rat models, subcutaneous injection of paclitaxel formulated with P(MPC/BMAx) did not adversely affect skin or tissue, and the complex accumulated predominantly in less vascular regions at the periphery of tumors.

Broader application areas surveyed include antibiofouling coatings for biodevices, biosensors that exploit the high surface-to-volume ratio of self-assembled nanostructures to immobilize enzymes such as glucose oxidase and hemoglobin, and stimuli-responsive drug release. Examples cited include PCL-ss-PMPC micelles in which disulfide bonds cleave in the reducing intracellular environment to release doxorubicin, pH-responsive polyion vesicles formed from cationic poly(MPC-b-MATAC) and anionic poly(MPC-b-AaH) that dissociate under acidic conditions, and CD-modified PMPC coupled to azobenzene-functionalized mesoporous silica nanoparticles that release diclofenac sodium under visible light through trans-to-cis isomerization. The review also describes optimization parameters, noting that roughly 30 to 37 molar percent MPC provides high hydrophilicity and a tightly bound hydration layer that repels proteins, bacteria, and platelets, while the hydrophobic comonomer supplies substrate adhesion and mechanical durability.

The review closes by identifying open problems that will shape future work. Random copolymers are described as physically and chemically less stable than their block counterparts, and precise sequence control of hydrophilic and hydrophobic units remains an unsolved challenge. Theoretical models of self-assembly often assume equilibrium, whereas real polymer systems are trapped in non-equilibrium states, and comprehensive in vivo studies of how sequence distribution affects protein corona formation are lacking. Long-term stability concerns include micellar dissociation upon dilution below the critical micelle concentration, kinetic transitions from spherical to rod-like morphologies, enzymatic degradation of the backbone, and hydrolysis over extended periods. Heavily cross-linked MPC polymers also suffer from poor biodegradability, prompting current research into cleavable bonds within MPC hydrogels and nanocarriers. As a whole, the review positions phosphorylcholine-containing amphiphilic copolymers as versatile, biomimetic platforms whose core-shell micelles, antifouling surfaces, and stimuli-responsive variants are expected to expand across drug delivery, implant technology, and biointerface engineering.

Subject of Research: Synthesis, characterization, and biomedical applications of amphiphilic copolymers with pendant phosphorylcholine groups

Article Title: A review of synthesis, characterizations, and biological activity of amphiphilic copolymers containing pendant phosphorylcholine groups

Article References: Barai, M. (2026). A review of synthesis, characterizations, and biological activity of amphiphilic copolymers containing pendant phosphorylcholine groups. Discover Polymers, 3(1), Article 30. https://doi.org/10.1007/s44347-026-00067-3

Image Credits: AI Generated

DOI: 10.1007/s44347-026-00067-3

Keywords: phosphorylcholine, amphiphilic copolymers, RAFT polymerization, polymeric micelles, drug delivery, paclitaxel, antifouling, DLS, TEM, biocompatibility, zwitterionic polymers, MPC